单位(元)招商国证生物医药指数分级A(150271)利润表 |
报告期 |
2020/12/31 |
2020/6/30 |
2019/12/31 |
2019/6/30 |
收入 |
-894,706,603 |
779,320,102 |
183,381,709 |
87,449,370 |
利息收入 |
2,562,059 |
305,605 |
251,713 |
98,685 |
其中:存款利息收入 |
2,283,230 |
257,141 |
157,813 |
73,394 |
债券利息收入 |
278,829 |
48,464 |
93,899 |
25,290 |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
-424,727,525 |
105,869,860 |
19,954,702 |
-4,977,092 |
其中:股票投资收益 |
-438,452,921 |
102,037,907 |
17,413,292 |
-6,378,966 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
1,645,464 |
11,557 |
-13,750 |
-13,750 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
12,079,933 |
3,820,396 |
2,555,161 |
1,415,624 |
公允价值变动收益 |
-532,636,233 |
668,434,485 |
162,116,261 |
91,865,992 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
60,095,095 |
4,710,152 |
1,059,033 |
461,786 |
费用 |
134,707,392 |
12,078,265 |
6,413,518 |
2,739,477 |
管理人报酬 |
73,138,911 |
6,412,801 |
4,211,936 |
1,818,826 |
托管费 |
16,090,560 |
1,410,816 |
926,626 |
400,142 |
销售服务费 |
- |
- |
- |
- |
交易费用 |
43,707,324 |
3,975,162 |
809,069 |
288,554 |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
1,770,585 |
279,485 |
465,888 |
231,955 |
利润总额 |
-1,029,413,995 |
767,241,837 |
176,968,191 |
84,709,893 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-1,029,413,995 |
767,241,837 |
176,968,191 |
84,709,893 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。